Showing 1561-1570 of 23120 results for "".
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
https://reachmd.com/programs/FDA-Drug-Information-Updates/fda-disco-l-glutamine-sickle-cell-disease/9773/FDA medical oncologists discuss the approval of l-glutamine to reduce the acute complications of sickle cell disease.FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
https://reachmd.com/programs/project-oncology/fda-disco-osimertinib-non-small-cell-lung-cancer/9774/FDA medical oncologists discuss the approval of osimertinib for EGFR mutation-positive non-small cell lung cancer.Interview with Pasquale Patrizio, MD, MBE, HCLD | USA
https://reachmd.com/programs/global-womens-health-academy/interview-pasquale-patrizio-md-mbe-hcld-usa/7791/Dr. Pasquale Patrizio, Professor of Obstetrics and Gynecology at Yale University School of Medicine, and Director of the Yale Fertility Center, discusses optimal criteria for implementing preimplantation genetic screening (PGS) for patients undergoing IVF treatment.Promoting Safe Sleeping Environments for Infants: Why Appearances are Deceiving
https://reachmd.com/programs/primary-care-today/promoting-safe-sleeping-environments-infants-why-appearances-are-deceiving/7289/Nearly 55% of infants in the United States sleep on unsafe bedding, despite warnings from the Centers for Disease Control and the American Academy of Sleep Medicine to use firm flat surfaces covered with fitted sheets. Parents are being presented with several more comfortable, "baby friendly" appearEconomics, Education, and Enterovirus: Three E-Barriers to Asthma/Allergy Care
https://reachmd.com/programs/primary-care-today/economics-education-and-enterovirus-three-e-barriers-to-asthmaallergy-care/7239/Dr. Brian McDonough welcomes Tanya Winders, President and Chief Executive Officer for the Allergy and Asthma Network, the leading patient advocacy organization dedicated to ending needless suffering and death due to asthma, allergies, and related conditions. They discuss ways of addressing healthcarCircumcision and HIV Risk in African Men
https://reachmd.com/programs/world-medical-news/circumcision-and-hiv-risk-in-african-men/7124/Recently published in the journal, AIDS and Behavior, researchers have conducted what they say is the first population-level longitudinal analysis of how adult male circumcision impacts risky sexual behavior.Exploring Pituitary Tumors: Diagnostic Considerations and Advanced Therapies
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/exploring-pituitary-tumors-diagnostic-considerations-advanced-therapies/7086/According to the American Cancer Society, about 10,000 pituitary tumors are diagnosed each year in the United States. What is the state of the art approach to the diagnosis and treatment of these tumors? Dr. Lee Freedman talks to Dr. Sean Grady, Chairman, Department of Neurosurgery Charles HarrisonLeveraging Technology for Medical Education
https://reachmd.com/programs/lifelong-learning/leveraging-technology-for-medical-education/6726/Technological innovations bring countless new opportunities to the world of continuing medical education. How are these advances being incorporated now, and what does the future hold for leveraging these resources toward improvements in patient care? Host Lawrence Sherman is joined by health technolThe Growth of Milk Banks for American Mothers
https://reachmd.com/programs/focus-on-nutrition-and-nutrition-science/the-growth-of-milk-banks-for-american-mothers/6312/With breast-feeding a hot topic across the nation and more women being encouraged to do so, there is a rise in the development of milk banks. Dr. Kathleen Marinelli, director of lactation support services at Connecticut Children's Medical Center and medical director of Mother's Milk Bank of New EnglTheatre as Therapy for Alzheimer's and Memory Loss
https://reachmd.com/programs/advances-in-long-term-care-medicine/theatre-as-therapy-for-alzheimers-and-memory-loss/5895/Although we remain limited in our options for treating patients with memory loss and Alzheimer's, there are a variety of non-pharmacologic treatments that are showing some promise. Mary O'Hara, social worker at Cognitive Neurology and Alzheimer's Disease Center at Northwestern University Feinberg Sc